← Back to headlines
MeiraGTx Considers $100M Equity Offering Following J&J Gene Therapy Deal
Biotechnology company MeiraGTx is exploring a $100 million equity offering, coming after its recent gene therapy agreement with pharmaceutical giant Johnson & Johnson.
16 Apr, 15:33 — 16 Apr, 15:33
Sources
Showing 1 of 1 sources
